Skip to content

Clinical trials

Observational Parkinsonian Disorders trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Parkinsonian Disorders Phase: Observational Country / region: United States Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20043
20061
20082
20091
20111
20124
20132
20151
20161
20172
20192
20201
20212
20221
20231
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Recruiting4
Active, not recruiting2
Unknown status2
Withdrawn2
Enrolling by invitation1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Neurological Disorders and Stroke (NINDS)5
Institute for Neurodegenerative Disorders3
National Heart, Lung, and Blood Institute (NHLBI)2
Bastyr University1
Beth Israel Deaconess Medical Center1
BlueRock Therapeutics1
CND Life Sciences1
Columbia University1
Icahn School of Medicine at Mount Sinai1
Milton S. Hershey Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Parkinsonian Disorders30
Parkinson Disease26
Supranuclear Palsy, Progressive8
Corticobasal Degeneration6
Multiple System Atrophy6
Huntington Disease3
Lewy Body Disease3
Movement Disorders3
Neurodegenerative Diseases3
Alzheimer Disease2

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.